Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / NOTE 0.750%10/1
-
Market price (% of par)
-
108.18%
-
Total 13F principal
-
$338,755,000
-
Principal change
-
-$10,085,000
-
Total reported market value
-
$367,571,182
-
Number of holders
-
42
-
Value change
-
-$11,587,554
-
Number of buys
-
12
-
Number of sells
-
12
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 as of Q4 2017
As of 31 Dec 2017,
BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 was held by
42 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$338,755,000
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, MACKAY SHIELDS LLC, CQS Cayman LP, DEUTSCHE BANK AG\, JPMORGAN CHASE & CO, CALAMOS ADVISORS LLC, BANK OF AMERICA CORP /DE/, BAKER BROS. ADVISORS LP, and STATE STREET CORP.
This page lists
43
institutional bondholders reporting positions
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.